Skip to Main Content Menu Search Site

Crisscross Nanoseed Detection: Nanotechnology-Powered Infectious Disease Diagnostics

Enzyme-free DNA nanotechnology for rapid, ultrasensitive, and low-cost detection of infectious disease biomarkers with broad accessibility in point-of-care settings

Interested in this technology?

The team is currently de-risking the Crisscross Nanoseed Detection technology and looking for industry collaborators and licensing partners to help advance their DNA nanotechnology-driven diagnostics approach towards commercial applications.

Close menu